Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial - Svensson, B; Boonen, A; Albertsson, K (Arthritis Rheum., 2005)
et al.